Health

Pfizer Advances Once-Daily Weight Loss Pill

Jul 11, 2024 1 min read

Jump to Summary

Pfizer plans to advance a once-daily version of its obesity pill, danuglipron, into clinical trials in the second half of this year. This decision follows encouraging data from early-stage trials, despite previously discontinuing a twice-daily version due to patient safety concerns, including issues with liver enzymes. The new formulation aims to offer a more convenient alternative to injections and is part of a broader effort among pharmaceutical companies, including Eli Lilly and Novo Nordisk, to develop second-generation weight loss pills.

Following the announcement, Pfizer's shares rose by 5% in premarket trading. Analysts predict the weight loss drug market could exceed $150 billion in annual sales by the early 2030s. However, Pfizer's stock has seen a significant decline since December 2021, largely due to decreased sales of its COVID-19 vaccine and pill, as well as investor concerns over its drug development pipeline. Additionally, Pfizer announced that Chief Scientific Officer Mikael Dolsten will step down after more than 15 years with the company.

#business #nutrition #world

Summary

Other news in health

Missouri's First Human Bird Flu Case Confirmed by CDC

Missouri's First Human Bird Flu Case Confirmed by CDC

The Centers for Disease Control and Prevention (CDC) has confirmed Missouri's first human case of avian influenza A (H5), identified through the Missouri Department of Health and Senior Services' (DHSS) influenza surveillance program. The patient, who has underlying medical conditions, was hospitalized on August 22, tested positive

Recalled Wisconsin Eggs Linked to Multistate Salmonella Outbreak, Dozens Ill

Recalled Wisconsin Eggs Linked to Multistate Salmonella Outbreak, Dozens Ill

The Wisconsin Department of Health Services (DHS) and the Department of Agriculture, Trade, and Consumer Protection (DATCP) are investigating a multistate outbreak of Salmonella infections linked to eggs from Milo's Poultry Farms. The eggs, distributed in Wisconsin, Illinois, and Michigan through retail stores and food service distributors, have

Gene Therapy Achieves Major Breakthrough in Restoring Vision

Gene Therapy Achieves Major Breakthrough in Restoring Vision

Researchers from the University of Pennsylvania have developed a gene therapy, ATSN-101, that has shown significant improvements in vision for patients with Leber congenital amaurosis type I (LCA1), a rare inherited condition that causes early childhood blindness. The therapy was administered via sub-retinal injections in both children and adults, resulting

AstraZeneca Employees Detained in China Amid Probes over Data and Drug Imports

AstraZeneca Employees Detained in China Amid Probes over Data and Drug Imports

Chinese authorities have detained five current and former employees of AstraZeneca, a British pharmaceutical company, amid allegations of illegal activities. The detained individuals, all Chinese citizens who worked in the company's oncology division, are being investigated for potential breaches of China's data privacy laws and the